resource-symbol

Comorbid Medical Conditions Questionnaire (CMCQ)

MacLean Elizabeth W; Palsson Olafur S; Turner Marsha J; Whitehead Williams E

Distributed by Mapi Research Trust

Distributed by Mapi Research Trust

default distrib
 

Basic description

Developed in 2012 simultaneously with the Recent Physical Symptoms Questionnaire (RPSQ)

Authors

MacLean Elizabeth W; Palsson Olafur S; Turner Marsha J; Whitehead Williams E

Copyright
Copyright 2014, Rome Foundation
Objective
To measure non-gastrointestinal symptoms that co-exist with Irritable Bowel Syndrome (IBS)
Therapeutic area
  • Digestive System Diseases
Therapeutic indication

Irritable Bowel Syndrome

Type of Clinical Outcome Assessment (COA)
  • PRO PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

MacLean EW, Palsson OS, Turner MJ, Whitehead WE. Development and validation of new disease-specific measures of somatization and comorbidity in IBS. J Psychosom Res. 2012 Nov;73(5):351-5 (Full Text Article)


Contact and conditions of use

Authors

MacLean Elizabeth W; Palsson Olafur S; Turner Marsha J; Whitehead Williams E

Olafur S. Palsson, PsyD
Professor of Medicine
Division of Gastroenterology and Hepatology
Center for Functional GI and Motility Disorders
130 Mason Farm Road
CB# 7080Chapel Hill, NC 27599
USA
Phone: +1 (919) 843-5932
Fax: +1 (919) 966-6842
E-Mail: opalsson@med.unc.edu

Olafur S. Palsson Publications(PubMed)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Submit your Request Online

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the User Agreement (even if not finalized) to your online request. See link below for the user agreement template
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Access fees

ROYALTY FEES* Commercial users Cost per study 1050 €
Cost per language 525 € per language version (existing or being developed)
Funded academic research Cost per study Free
Cost per language Free
Not funded academic users Cost per study Free
Cost per language Free
DISTRIBUTION FEES* Commercial users Cost per study 1 000 €
Cost per language 500 €
Funded academic research Cost per study 300 €
Cost per language 50 €
Not funded academic users Cost per study Free
Cost per language Free

* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the USA

Translations

The translations listed may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

CMCQ

Japanese for Japan

Conditions to translate

USER shall not translate the Questionnaire, without the prior written agreement of the OWNER.

Specific translation processes are required by the OWNER for the development of any new translations and must be followed. Mapi Research Trust will provide guidance on the process.

Please contact Mapi

More information on translations

Last update: June 2016
For additional information, please submit a request. More information in our FAQs.